Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Pramlintide

APP

AstraZeneca · Not applicable · Recruiting · Enrollment 18

NCT07506369

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
Amylin (Pramlintide) + Placebon/rn/rn/rn/r
PP + Placebon/rn/rn/rn/r
Amylin (Pramlintide) + PPn/rn/rn/rn/r
Placebo + Placebon/rn/rn/rn/r

Not shown

  • Amylin (Pramlintide) + Placebo: endpoint not reported
  • PP + Placebo: endpoint not reported
  • Amylin (Pramlintide) + PP: endpoint not reported
  • Placebo + Placebo: endpoint not reported